Evidence map›Paper›PMID 36044090›Full record

ArticleParasitology research2022

Proteomic analysis of the excretory-secretory products from Strongyloides venezuelensis infective larvae: new insights for the immunodiagnosis of human strongyloidiasis.

William Henry Roldán Gonzáles, Guilherme Rabelo Coelho, Daniel Carvalho Pimenta, Fabiana Martins de Paula, Ronaldo Cesar Borges Gryschek

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Progresses and challenges inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

William Henry Roldán GonzálesLaboratório de Investigação Médica (LIM/06), Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
Guilherme Rabelo CoelhoLaboratório de Bioquímica e Biofísica, Instituto Butantan, São Paulo, SP, Brasil.
Daniel Carvalho PimentaLaboratório de Bioquímica e Biofísica, Instituto Butantan, São Paulo, SP, Brasil.
Fabiana Martins de PaulaLaboratório de Investigação Médica (LIM/06), Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. fabiana.paula@hc.fm.usp.br.
Ronaldo Cesar Borges GryschekLaboratório de Investigação Médica (LIM/06), Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
Instituto Butantan · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRInstituto de Medicina Tropical · PYUniversidade de São Paulo · BR

Funding

Edital MCT/CNPq-Brazil Process N° 142056/2018-9Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil (FAPESP) Grant N° 2013/04236-9
6 · The paper itself

Abstract

Serodiagnosis of human strongyloidiasis is a practical alternative to parasitological methods due to its high sensitivity. However, cross-reactivity with other helminth infections limits its utility, and this problem is due to the use of homologous or heterologous somatic extracts of the parasite as an antigen source. Excretory-secretory (E/S) products from Strongyloides infective larvae can be used to improve the serodiagnosis. The combined use of western blot and proteomics became an interesting strategy to identify immunological markers for the serodiagnosis of strongyloidiasis. The present study describes the proteomic analysis of the antigenic components from E/S products of S. venezuelensis infective larvae that were recognized by IgG antibodies from patients with strongyloidiasis. Our results showed that IgG antibodies from patients with strongyloidiasis recognized between 15 and 16 antigenic bands in the E/S products from S. venezuelensis that were incubated in PBS or in RPMI culture medium, respectively. Overall, antigenic bands of low and high molecular weight were more specific than those of intermediate molecular weight, which were cross-reactive. A 36-kDa antigenic band was 93% sensitive and 100% specific (a probably arginine kinase of 37 kDa), while other antigenic bands were highly sensitive but low specific. Proteomic analysis revealed differences between the protein profiles from E/S-RPMI and E/S-PBS since only one-third of all proteins identified were common in both types of E/S products. Bioinformatic analysis showed that more than 50% of the proteins from E/S products are secreted within extracellular vesicles and only a small percentage of them are actually released by the classical secretory pathway. Several components from the E/S products were identified as plasminogen-binding proteins, probably used as an immune evasion mechanism. The data provided here provide valuable information to increase understanding of E/S products from S. venezuelensis infective larvae. This may help us to find new targets for the immunodiagnosis of human strongyloidiasis.

Indexed as

Arginine KinaseStrongyloidiasisAnimalsAntibodies, HelminthAntigens, HelminthEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GLarvaPlasminogenProteomicsSerologic TestsStrongyloidesAntibodies, HelminthAntigens, HelminthArginine KinaseImmunoglobulin GPlasminogenAntibodyAntigenExcretory-secretory productsProteomicsStrongyloidesWestern blot

Identifiers

PMID36044090
OpenAlexW4293715599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.